Genetics testing company 23andMe has filed for Chapter 11 bankruptcy protection in the U.S.The CEO, Anne Wojcicki, has resigned and is now an independent bidder for the company.The company's market capitalization has plummeted over 99% since going public in 2021.23andMe suffered a cyberattack in 2023, leading to a data breach and subsequent legal issues.